Feature

CMS finalizes measures to help combat opioid crisis


 


The president’s plan also calls for ensuring first-responder access to naloxone, improving overdose tracking systems, and expanding access to medication-assisted treatment. It also aims to change the Medicaid law that prohibits reimbursement of residential treatment at certain facilities with more than 16 beds.

On the legislative side, the House Energy and Commerce Committee is in the process of hosting a series of hearings and is expected to introduce a comprehensive package of bills aimed at various aspects of the opioid crisis. Across the four hearings, more than 30 pieces of individual legislation have been examined.

In the Senate, the Health, Education, Labor and Pensions Committee on April 4 released a discussion draft of the Opioid Crisis Response Act of 2018 and has scheduled a hearing for April 11 to discuss it.

The bill would spur development of nonaddictive pain killers, clarify FDA authority on small-quantity blister packs for opioids, provide states with better PDMP support; increase access to mental health services in schools, and improve substance use disorder treatment in underserved areas.

Pages

Recommended Reading

Opioids linked to mortality in IBD
MDedge Internal Medicine
Intramuscular steroid injection reduced hip OA pain up to 12 weeks
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Abstract: The Opioid Crisis and the Need for Compassion in Pain Management
MDedge Internal Medicine
Is kratom the answer to the opioid crisis?
MDedge Internal Medicine
Abstract: Don't demonise prescription opioids
MDedge Internal Medicine
FDA advisors recommend lofexidine for opioid withdrawal
MDedge Internal Medicine
FDA recalls kratom products for salmonella contamination
MDedge Internal Medicine
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Internal Medicine
Sensitivity of vibration-based neuropathy detectors varies widely
MDedge Internal Medicine